UPDATE 1-U.S. regulator charges two Chileans with insider trading
December 22, 2014 at 18:12 PM EST
NEW YORK/SANTIAGO (Reuters) - A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.